M. Sherry Ku

Use of the Biopharmaceutical Classification System in Early Drug Development

M. Sherry Ku · The AAPS Journal · 2008 · 219 citations · Full text

Preclinical Drug Evaluation, Bioanalysis, Pharmacology +7

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

Barbara J. Ring, Jenny Y. Chien, Kimberly K. Adkison et al. · Journal of Pharmaceutical Sciences · 2011 · 198 citations

Pharmacokinetic Modeling, Medicine, Drug Discovery +8

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach

Patrick Poulin, Rhys D.O. Jones, Hannah M. Jones et al. · Journal of Pharmaceutical Sciences · 2011 · 170 citations

Precision Dosing, Physiologically Based Pharmacokinetics, Pharmacokinetic Modeling +9

A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept

M. Sherry Ku, Wendy Dulin · Pharmaceutical Development and Technology · 2010 · 170 citations

Pharmaceutical Science, Engineering, Project Cycle Time +21

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution

Rhys D.O. Jones, Hannah M. Jones, Malcolm Rowland et al. · Journal of Pharmaceutical Sciences · 2011 · 133 citations

Translational Medicine, Pharmacokinetic Modeling, Part 2 +11